1,016
Views
11
CrossRef citations to date
0
Altmetric
PhD Reviews

The Bandim TBscore – reliability, further development, and evaluation of potential uses

Article: 24303 | Received 09 Mar 2014, Accepted 28 Apr 2014, Published online: 22 May 2014

References

  • Daniel TM. The history of tuberculosis. Respir Med. 2006; 100: 1862–70.
  • Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, etal. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2013; 380: 2095–128.
  • WHO. Global tuberculosis report 2013. 2014; Geneva: WHO. [cited 1 March 2014].
  • Lienhardt C, Glaziou P, Uplekar M, Lonnroth K, Getahun H, Raviglione M. Global tuberculosis control: lessons learnt and future prospects. Nat Rev Microbiol. 2012; 10: 407–16.
  • WHO. Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. 2010. Available from: http://www.who.int/tb/features_archive/m_xdrtb_facts/en/index.html [cited 1 December 2012]..
  • Small PM, Pai M. Tuberculosis diagnosis – time for a game change. N Engl J Med. 2010; 363: 1070–1.
  • Bloss E, Makombe R, Kip E, Smit M, Chirenda J, Gammino VM, etal. Lessons learned during tuberculosis screening in public medical clinics in Francistown, Botswana. Int J Tuberc Lung Dis. 2012; 16: 1030–2.
  • Cain KP, Varma JK. You have to find TB to treat TB. Int J Tuberc Lung Dis. 2011; 15: 854.
  • Hoa NB, Sy DN, Nhung NV, Tiemersma EW, Borgdorff MW, Cobelens FG. National survey of tuberculosis prevalence in Viet Nam. Bull World Health Organ. 2010; 88: 273–80.
  • Raviglione M, Marais B, Floyd K, Lonnroth K, Getahun H, Migliori GB, etal. Scaling up interventions to achieve global tuberculosis control: progress and new developments. Lancet. 2012; 379: 1902–13.
  • WHO. Early detection of tuberculosis – an overview of approaches, guidelines and tools. 2011. Available from: http://whqlibdoc.who.int/hq/2011/WHO_HTM_STB_PSI_2011.21_eng.pdf [cited 1 December 2013]..
  • McNerney R, Maeurer M, Abubakar I, Marais B, McHugh TD, Ford N, etal. Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities. J Infect Dis. 2012; 205: S147–S58.
  • Perkins MD, Cunningham J. Facing the crisis: improving the diagnosis of tuberculosis in the HIV era. J Infect Dis. 2007; 196: S15–S27.
  • Straetemans M, Glaziou P, Bierrenbach AL, Sismanidis C, van der Werf MJ. Assessing tuberculosis case fatality ratio: a meta-analysis. PLoS One. 2011; 6: e20755.
  • Waitt CJ, Squire SB. A systematic review of risk factors for death in adults during and after tuberculosis treatment. Int J Tuberc Lung Dis. 2011; 15: 871–85.
  • Wejse C, Gustafson P, Nielsen J, Gomes VF, Aaby P, Andersen PL, etal. TBscore: signs and symptoms from tuberculosis patients in a low-resource setting have predictive value and may be used to assess clinical course. Scand J Infect Dis. 2008; 40: 111–20.
  • Reilly BM, Evans AT. Translating clinical research into clinical practice: impact of using prediction rules to make decisions. Ann Intern Med. 2006; 144: 201–9.
  • Beattie P, Nelson R. Clinical prediction rules: what are they and what do they tell us?. Aust J Physiother. 2006; 52: 157–63.
  • McGinn TG, Guyatt GH, Wyer PC, Naylor CD, Stiell IG, Richardson WS. Users’ guides to the medical literature: XXII: how to use articles about clinical decision rules. Evidence-Based Medicine Working Group. JAMA. 2000; 284: 79–84.
  • Barrett TW, Schriger DL. Annals of emergency medicine journal club. Clinical prediction rules answers to the November 2009 journal club. Ann Emerg Med. 2010; 55: 380–9.
  • Schag CC, Heinrich RL, Ganz PA. Karnofsky performance status revisited: reliability, validity, and guidelines. J Clin Oncol. 1984; 2: 187–93.
  • Karnofsky DA. Nitrogen mustards in the treatment of neoplastic disease. Adv Intern Med. 1950; 4: 1–75.
  • Villamor E, Saathoff E, Mugusi F, Bosch RJ, Urassa W, Fawzi WW. Wasting and body composition of adults with pulmonary tuberculosis in relation to HIV-1 coinfection, socioeconomic status, and severity of tuberculosis. Eur J Clin Nutr. 2006; 60: 163–71.
  • Wilson D, Nachega J, Morroni C, Chaisson R, Maartens G. Diagnosing smear-negative tuberculosis using case definitions and treatment response in HIV-infected adults. Int J Tuberc Lung Dis. 2006; 10: 31–8.
  • Meintjes G, Wilkinson RJ, Morroni C, Pepper DJ, Rebe K, Rangaka MX, etal. Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS. 2010; 24: 2381–90.
  • Mugusi FM, Mehta S, Villamor E, Urassa W, Saathoff E, Bosch RJ, etal. Factors associated with mortality in HIV-infected and uninfected patients with pulmonary tuberculosis. BMC Public Health. 2009; 9: 409.
  • Aguiar F, Almeida L, Ruffino-Netto A, Kritski A, Mello F, Werneck G. Classification and regression tree (CART) model to predict pulmonary tuberculosis in hospitalized patients. BMC Pulm Med. 2012; 12: 40.
  • Rakoczy KS, Cohen SH, Nguyen HH. Derivation and validation of a clinical prediction score for isolation of inpatients with suspected pulmonary tuberculosis. Infect Control Hosp Epidemiol. 2008; 29: 927–32.
  • Solari L, Acuna-Villaorduna C, Soto A, Agapito J, Perez F, Samalvides F, etal. A clinical prediction rule for pulmonary tuberculosis in emergency departments. Int J Tuberc Lung Dis. 2008; 12: 619–24.
  • Solari L, Acuna-Villaorduna C, Soto A, van der Stuyft P. Evaluation of clinical prediction rules for respiratory isolation of inpatients with suspected pulmonary tuberculosis. Clin Infect Dis. 2011; 52: 595–603.
  • Wisnivesky JP, Kaplan J, Henschke C, McGinn TG, Crystal RG. Evaluation of clinical parameters to predict Mycobacterium tuberculosis in inpatients. Arch Intern Med. 2000; 160: 2471–6.
  • Alavi-Naini R, Cuevas LE, Squire SB, Mohammadi M, Davoudikia AA. Clinical and laboratory diagnosis of the patients with sputum smear-negative pulmonary tuberculosis. Arch Iran Med. 2012; 15: 22–6.
  • Mello FC, Bastos LG, Soares SL, Rezende VM, Conde MB, Chaisson RE, etal. Predicting smear negative pulmonary tuberculosis with classification trees and logistic regression: a cross-sectional study. BMC Public Health. 2006; 6: 43.
  • Soto A, Solari L, Agapito J, Acuna-Villaorduna C, Lambert ML, Gotuzzo E, etal. Development of a clinical scoring system for the diagnosis of smear-negative pulmonary tuberculosis. Braz J Infect Dis. 2008; 12: 128–32.
  • Alacantara CC, Kritski AL, Ferreira VG, Facanha MC, Pontes RS, Mota RS, etal. Factors associated with pulmonary tuberculosis among patients seeking medical attention at referral clinics for tuberculosis. J Bras Pneumol. 2012; 38: 622–9.
  • Fournet N, Sanchez A, Massari V, Penna L, Natal S, Biondi E, etal. Development and evaluation of tuberculosis screening scores in Brazilian prisons. Public Health. 2006; 120: 976–83.
  • Corbett EL, Zezai A, Cheung YB, Bandason T, Dauya E, Munyati SS, etal. Provider-initiated symptom screening for tuberculosis in Zimbabwe: diagnostic value and the effect of HIV status. Bull World Health Organ. 2010; 88: 13–21.
  • Hanifa Y, Fielding KL, Charalambous S, Variava E, Luke B, Churchyard GJ, etal. Tuberculosis among adults starting antiretroviral therapy in South Africa: the need for routine case finding. Int J Tuberc Lung Dis. 2012; 16: 1252–9.
  • Horita N, Miyazawa N, Yoshiyama T, Sato T, Yamamoto M, Tomaru K, etal. Development and validation of a tuberculosis prognostic score for smear-positive in-patients in Japan. Int J Tuberc Lung Dis. 2013; 17: 54–60.
  • Rieder HL, Arnadottir T, Tardencilla Gutierrez AA, Kasalika AC, Salaniponi FL, Ba F, etal. Evaluation of a standardized recording tool for sputum smear microscopy for acid-fast bacilli under routine conditions in low income countries. Int J Tuberc Lung Dis. 1997; 1: 339–45.
  • Davies PD, Pai M. The diagnosis and misdiagnosis of tuberculosis. Int J Tuberc Lung Dis. 2008; 12: 1226–34.
  • Donald PR, Marais BJ, Barry CE III. Age and the epidemiology and pathogenesis of tuberculosis. Lancet. 2010; 375: 1852–4.
  • Lawn SD, Wood R. Tuberculosis in antiretroviral treatment services in resource-limited settings: addressing the challenges of screening and diagnosis. J Infect Dis. 2011; 204: S1159–S67.
  • Achkar JM, Jenny-Avital ER. Incipient and subclinical tuberculosis: defining early disease states in the context of host immune response. J Infect Dis. 2011; 204: S1179–S86.
  • WHO. Guidelines for treatment of tuberculosis. 4th ed. 2010. Available from: http://www.who.int/tb/publications/2010/9789241547833/en/index.html [cited 1 October 2012]..
  • Goodridge A, Cueva C, Lahiff M, Muzanye G, Johnson JL, Nahid P, etal. Anti-phospholipid antibody levels as biomarker for monitoring tuberculosis treatment response. Tuberculosis (Edinb). 2012; 92: 243–7.
  • Horne DJ, Royce SE, Gooze L, Narita M, Hopewell PC, Nahid P, etal. Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis. Lancet Infect Dis. 2010; 10: 387–94.
  • Rabna P, Andersen A, Wejse C, Oliveira I, Gomes VF, Haaland MB, etal. Utility of the plasma level of suPAR in monitoring risk of mortality during TB treatment. PLoS One. 2012; 7: e43933.
  • Wallis RS, Pai M, Menzies D, Doherty TM, Walzl G, Perkins MD, etal. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet. 2010; 375: 1920–37.
  • Farnia P, Mohammadi F, Mirsaedi M, Zarife AZ, Tabatabee J, Bahadori K, etal. Application of oxidation-reduction assay for monitoring treatment of patients with pulmonary tuberculosis. J Clin Microbiol. 2004; 42: 3324–5.
  • Kennedy N, Ramsay A, Uiso L, Gutmann J, Ngowi FI, Gillespie SH. Nutritional status and weight gain in patients with pulmonary tuberculosis in Tanzania. Trans R Soc Trop Med Hyg. 1996; 90: 162–6.
  • Schwenk A, Hodgson L, Wright A, Ward LC, Rayner CF, Grubnic S, etal. Nutrient partitioning during treatment of tuberculosis: gain in body fat mass but not in protein mass. Am J Clin Nutr. 2004; 79: 1006–12.
  • Suttmann U, Ockenga J, Selberg O, Hoogestraat L, Deicher H, Muller MJ. Incidence and prognostic value of malnutrition and wasting in human immunodeficiency virus-infected outpatients. J Acquir Immune Defic Syndr Hum Retrovirol. 1995; 8: 239–46.
  • Rudolf F, Joaquim LC, Vieira C, Bjerregaard-Andersen M, Andersen A, Erlandsen M, etal. The Bandim tuberculosis score: reliability and comparison with the Karnofsky performance score. Scand J Infect Dis. 2013; 45: 256–64.
  • Rudolf F, Lemvik G, Abate E, Verkuilen J, Schon T, Gomes VF, etal. TBscore II: refining and validating a simple clinical score for treatment monitoring of patients with pulmonary tuberculosis. Scand J Infect Dis. 2013; 45: 825–36.
  • Rudolf F, Haraldsdottir TL, Mendes MS, Wagner A-J, Gomes VF, Aaby P, etal. Can tuberculosis case-finding among health-care seeking adults be improved? – observations from Bissau. Int J Tuberc Lung Dis. 2014; 18: 277–85.
  • WHO. Guinea Bissau – tuberculosis profile. 2013. Available from: http://www.who.int/tb/data [cited 22 January 2013]..
  • WHO. Ethiopia – tuberculosis profile. 2013. Available from: http://www.who.int/tb/data [cited 22 January 2013]..
  • Sim J, Wright CC. The kappa statistic in reliability studies: use, interpretation, and sample size requirements. Phys Ther. 2005; 85: 257–68.
  • Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med. 2005; 37: 360–3.
  • Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979; 86: 420–8.
  • Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986; 1: 307–10.
  • Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res. 1999; 8: 135–60.
  • Floyd FJ, Widaman KF. Factor analysis in the development and refinement of clinical assessment instruments. Psychol Assess. 1995; 7: 286–99.
  • Husted JA, Cook RJ, Farewell VT, Gladman DD. Methods for assessing responsiveness: a critical review and recommendations. J Clin Epidemiol. 2000; 53: 459–68.
  • Soreide K. Receiver-operating characteristic curve analysis in diagnostic, prognostic and predictive biomarker research. J Clin Pathol. 2009; 62: 1–5.
  • Kind P. Measuring quality of life in evaluating clinical interventions: an overview. Ann Med. 2001; 33: 323–7.
  • van Wesenbeeck CF, Keyzer MA, Nube M. Estimation of undernutrition and mean calorie intake in Africa: methodology, findings and implications. Int J Health Geogr. 2009; 8: 37.
  • Krapp F, Veliz JC, Cornejo E, Gotuzzo E, Seas C. Bodyweight gain to predict treatment outcome in patients with pulmonary tuberculosis in Peru. Int J Tuberc Lung Dis. 2008; 12: 1153–9.
  • Janols H, Abate E, Idh J, Senbeto M, Britton S, Alemu S, etal. Early treatment response evaluated by a clinical scoring system correlates with the prognosis of pulmonary tuberculosis patients in Ethiopia: a prospective follow-up study. Scand J Infect Dis. 2012; 44: 828–34.
  • WHO. Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. 2013. Available from: http://www.who.int/hiv/pub/tb/9789241500708/en/index.html [cited 15 December 2012]..
  • Fan J, Upadhye S, Worster A. Understanding receiver operating characteristic (ROC) curves. CJEM. 2006; 8: 19–20.
  • WHO. TB/HIV: a clinical manual. 2004. Available from: http://www.who.int/tb/publications/who_htm_tb_2004_329/en/ [cited 1 December 2012]..
  • Wilkinson D, Newman W, Reid A, Squire SB, Sturm AW, Gilks CF. Trial-of-antibiotic algorithm for the diagnosis of tuberculosis in a district hospital in a developing country with high HIV prevalence. Int J Tuberc Lung Dis. 2000; 4: 513–18.
  • Harries AD, Maher D, Nunn P. An approach to the problems of diagnosing and treating adult smear-negative pulmonary tuberculosis in high-HIV-prevalence settings in sub-Saharan Africa. Bull World Health Organ. 1998; 76: 651–62.
  • Streiner DL, Norman GR. Devising the items. Health measurement scales: a practical guide to their development and use. 4th ed. 2008; Oxford, New York: Oxford University Press. 17–36.
  • Feng JY, Su WJ, Chiu YC, Huang SF, Lin YY, Huang RM, etal. Initial presentations predict mortality in pulmonary tuberculosis patients – a prospective observational study. PLoS One. 2011; 6: e23715.
  • Getahun B, Ameni G, Biadgilign S, Medhin G. Mortality and associated risk factors in a cohort of tuberculosis patients treated under DOTS programme in Addis Ababa, Ethiopia. BMC Infect Dis. 2011; 11: 127.
  • Tabarsi P, Chitsaz E, Moradi A, Baghaei P, Farnia P, Marjani M, etal. Treatment outcome, mortality and their predictors among HIV-associated tuberculosis patients. Int J STD AIDS. 2012; 23: e1–e4.
  • Kourbatova EV, Borodulin BE, Borodulina EA, del RC, Blumberg HM, Leonard MK, Jr. Risk factors for mortality among adult patients with newly diagnosed tuberculosis in Samara, Russia. Int J Tuberc Lung Dis. 2006; 10: 1224–30.